A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension

Clinical Therapeutics ◽

10.1016/j.clinthera.2021.08.003 ◽

2021 ◽

Author(s):

Hae-Young Lee ◽

Kwang-il Kim ◽

Sang Hyun Ihm ◽

Moo-Yong Rhee ◽

Il Suk Sohn ◽

...

Keyword(s):

Essential Hypertension ◽

Elderly Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Multicenter Phase ◽

Parallel Group ◽

Download Full-text

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Epilepsy & Behavior ◽

10.1016/j.yebeh.2020.106962 ◽

2020 ◽

Vol 105 ◽

pp. 106962 ◽

Author(s):

Fenella Kirkham ◽

Stéphane Auvin ◽

Joana Moreira ◽

Helena Gama ◽

Amílcar C. Falcão ◽

...

Keyword(s):

Clinical Trial ◽

Adjunctive Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase ◽

Download Full-text

A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.04.005 ◽

2016 ◽

Vol 38 (6) ◽

pp. 1485-1497 ◽

Author(s):

Jang Hoon Lee ◽

Dong Heon Yang ◽

Jin Yong Hwang ◽

Seung Ho Hur ◽

Tae Joon Cha ◽

...

Keyword(s):

Clinical Trial ◽

Essential Hypertension ◽

Moderate Essential Hypertension ◽

Antihypertensive Efficacy ◽

Group Comparison ◽

Efficacy And Safety ◽

Double Blind ◽

Download Full-text

A DOUBLE BLIND, RANDOMIZED, PARALLEL GROUP, PROSPECTIVE, CLINICAL STUDY FOR EVALUATION OF EFFICACY AND SAFETY OF LOW DOSE DOXEPIN IN COMPARISION WITH ZOPICLONE IN ADULT AND ELDERLY PATIENTS WITH PRIMARY INSOMNIA

Journal of Evolution of Medical and Dental Sciences ◽

10.14260/jemds/2015/2241 ◽

2015 ◽

Vol 4 (91) ◽

pp. 15603-15608

Author(s):

Pali Rastogi ◽

Deepti Rastogi

Keyword(s):

Clinical Study ◽

Elderly Patients ◽

Low Dose ◽

Primary Insomnia ◽

Prospective Clinical Study ◽

Efficacy And Safety ◽

Double Blind ◽

Download Full-text

Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)

Drug Design Development and Therapy ◽

10.2147/dddt.s231293 ◽

2020 ◽

Vol Volume 14 ◽

pp. 347-360

Author(s):

Woo-Baek Chung ◽

Sang-Hyun Ihm ◽

Sung-Won Jang ◽

Sung-Ho Her ◽

Chul Soo Park ◽

...

Keyword(s):

Blood Pressure ◽

Essential Hypertension ◽

Systolic Blood Pressure ◽

Active Control ◽

Ambulatory Blood Pressure ◽

Moderate Essential Hypertension ◽

Blood Pressure Target ◽

Double Blind ◽

Multicenter Phase ◽

Download Full-text

A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study

Hypertension Research ◽

10.1038/hr.2009.163 ◽

2009 ◽

Vol 32 (12) ◽

pp. 1148-1154 ◽

Author(s):

Toshio Ogihara ◽

Takao Saruta ◽

Kazuyuki Shimada ◽

Kizuku Kuramoto

Keyword(s):

Essential Hypertension ◽

Combination Therapy ◽

Olmesartan Medoxomil ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group Study ◽

Download Full-text

A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.07.008 ◽

2016 ◽

Vol 38 (10) ◽

pp. 2159-2170 ◽

Author(s):

Kwang-il Kim ◽

Mi-Seung Shin ◽

Sang-Hyun Ihm ◽

Ho-Joong Youn ◽

Ki-Chul Sung ◽

...

Keyword(s):

Essential Hypertension ◽

Combined Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Multicenter Phase ◽

Phase Iii Study

Download Full-text

548 A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, ACTIVE CONTROLLED MULTI-CENTER CLINICAL TRIAL TO EVALUATE THE ADDITIONAL EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL/AMLODIPINE 20/5 MG IN CHINESE PATIENTS WITH MILD OR MODERATE ESSENTIAL HYPERTENSION WHO FAILED TO ACHIEVE THEIR GOAL WITH AMLODIPINE 5MG MONOTHERAPY

Journal of Hypertension ◽

10.1097/01.hjh.0000420822.48472.89 ◽

2012 ◽

Vol 30 ◽

pp. e161

Author(s):

Ping-Jin Gao ◽

Jun-Ren Zhu

Keyword(s):

Clinical Trial ◽

Essential Hypertension ◽

Olmesartan Medoxomil ◽

Moderate Essential Hypertension ◽

Chinese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Download Full-text

Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder

Current Therapeutic Research ◽

10.1016/j.curtheres.2009.11.001 ◽

2009 ◽

Vol 70 (6) ◽

pp. 405-420 ◽

Author(s):

Franklin Chu ◽

Neila Smith ◽

Takeshi Uchida

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicenter Phase ◽

Solifenacin Succinate ◽

Parallel Group ◽

Parallel Group Trial ◽

Download Full-text

Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial

Diabetes Care ◽

10.2337/dc20-0763 ◽

2021 ◽

pp. dc200763

Author(s):

Julie Dubourg ◽

Pascale Fouqueray ◽

Carole Thang ◽

Jean-Marie Grouin ◽

Kohjiro Ueki

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Multicenter Phase ◽

Download Full-text

Efficacy and Safety of Mirodenafil Oro-Dispersible Film in Korean Patients with Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Phase IV Study

The World Journal of Men s Health ◽

10.5534/wjmh.200157 ◽

2021 ◽

Vol 39 ◽

Author(s):

Sung Won Lee ◽

Hwancheol Son ◽

Seung Wook Lee ◽

Kang Su Cho ◽

Du Geon Moon ◽

...

Keyword(s):

Erectile Dysfunction ◽

Efficacy And Safety ◽

Double Blind ◽

Korean Patients ◽

Multicenter Phase ◽

Parallel Group ◽

Download Full-text